China BCT Pharmacy Group, Inc.

CNBI · OTC
Analyze with AI
12/31/2012
12/31/2011
12/31/2010
12/31/2009
Operating Activities
Net Income$21,051$31,191$25,689$19,409
Dep. & Amort.$1,822$1,442$1,189$1,030
Deferred Tax-$361-$727-$91$11
Stock-Based Comp.$637$1,640$1,254$0
Change in WC-$33,955-$38,174-$11,601-$13,686
Other Non-Cash$1,219-$501-$549$157
Operating Cash Flow-$9,587-$5,128$15,889$6,921
Investing Activities
PP&E Inv.-$5,763-$4,072-$450-$71
Net Acquisitions$0$37-$6,038$0
Inv. Purchases-$602-$3,397$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0-$12-$2,682$1,414
Investing Cash Flow-$6,366-$7,444-$9,169$1,343
Financing Activities
Debt Repay.$6,724-$1,979-$2,494-$2,056
Stock Issued$0$0$2,315$5,307
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$707-$5,360-$349$457
Financing Cash Flow$5,931$22,157-$528$3,707
Forex Effect$151$1,738$661$68
Net Chg. in Cash-$9,871$11,322$6,853$12,039
Supplemental Information
Beg. Cash$31,480$20,157$13,304$1,265
End Cash$21,609$31,480$20,157$13,304
Free Cash Flow-$15,350-$9,218$15,439$6,849